November 19, 2018 8:36am

One trader’s golden upside is another’s disposable tin

 

I post about “indication intelligence” devoting my time to collection and analysis of information to assist investors in the perception of sector vulnerabilities and strengths – it’s more than opinion, the facts and truth need to be recognized!

A trusted source of factual reporting of preludes and aftermaths!

U.S. stock index futures are more than a tad low

Dow futures are DOWN -0.32% (-82 points) and NASDAQ futures are DOWN -0.44% (-30 points)

 

U.S. stock index futures were slightly lower but still indicating a questionable start to the trading day for the major U.S. indexes.

European markets are higher despite Brexit turmoil

Asian markets were higher despite global uncertainties on trade and Brexit

 

Data docket: the National Association of Home Builders (NAHB) was expected to publish its survey for November at around 10:00 a.m. ET.

 

Monday’s indications:

The iShares Nasdaq Biotechnology (IBB) is indicating a NEGATIVE -0.22% downside;

The SPDR S&P Biotech ETF (XBI) is indicating a NEGATIVE -0.05% downside;

The Health Care Select Sector SPDR ETF (XLV) is indicating a POSITIVE +0.04% upside

The iShares Russell 2000 (IWM) is indicating a NEGATIVE -0.1% downside

 

Henry’omics:

Just another dour Monday and the early snow have soured my mood. Thanks for a short week as many will be traveling early to escape the crowded highways.

Futures on the S&P and NASDAQ were marginally lower Monday morning but point to a positive open.

I keep saying, the sector is a game in motion – today its pool after the break there are too many scattered balls without clear shots to the pockets!

I’ll let others move the table to line-up shots!

 

From Friday’s night’s newsletter: “volume is and isn’t the determinant. The tug-of-war of volatility with strong moves to the upside and weakness to the down.”

Friday’s percentage (%) indicators:

  • Review the range of the 28 upside from +0.18% (STML) to +9.09% (SLDB) while the 14 downside ranged from -0.30% (ADRO) to -5% (KOOL -$0.02) with 3 flat closes (BSTG, PSTI and RENE.L).

Volume stat:

  • 7 out of 28 of the upside had higher (than the 3 month average) volume
  • 3 out of the 14 downside experienced greater volume (than the 3 month average).

The iShares NASDAQ Biotechnology (IBB) in a week’s history lesson; a five session aggregate of a negative -2.38% after yesterday’s -8.41% after 3 downside sessions out of 5!

  • In 12 session in November – there were 5 positive closes, 1 neutral and 6 negative closes
  • In 23 sessions in October – there were 17 negative closes and 6 positive sessions;
  • In 19 sessions in September – there were 10 negative closes and 9 positive sessions;
  • In 21 August sessions – 6 had negative and 15 had positive closes

 

Companies in my headlights – It’s your decision; I provide an idea and context:

 

*****I’m waiting until I see the green of the opening traffic lights and then the first hours moves *****

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.